Perinatal Outcomes in Patients With Elevated sFlt-1/PlGF Ratio
- Conditions
- Hypertension in Pregnancy
- Registration Number
- NCT06403722
- Lead Sponsor
- Saint Thomas Hospital, Panama
- Brief Summary
Retrospective cohort study that evaluated 190 subjects admitted with diagnosis of hypertensive disorder of pregnancy, between 24 and 36 6/7 weeks, with an sFlt-1/PlGF index greater than or equal to 110. Data were collected on their clinical course prior to termination of pregnancy, using the last reported sFlt-1/PlGF ratio value to classify the population into four cohorts: values between 110-205, between 206 and 654, between 655 and 999 and greater than 1000.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 190
- Diagnosis of hypertensive disorder of pregnancy
- Gestational age between 24 - 36 6/7
- sFlt-1/PlGF > 110
- Gestational age below 23 6/7 weeks and above 37 weeks at the moment of admission.
- Absence of sFLt-1/PlGF ratio result.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Hepatic enzyme abnormalities From the moment of admission up until discharge after delivery, average 5 to 10 days Increase of liver enzyme to \> twice the upper limit of normal
Kidney injury From the moment of admission up until discharge after delivery, average 5 to 10 days Creatinine level \> 1.1 Doubling of creatinine levels when others causes had been excluded
Growth restricted fetus From the moment of admission up until delivery, average 5 to 10 days Fetal weight below 10th percentile and abnormal doppler Fetal weight below 3th percentile
HELLP Syndrome From the moment of admission up until discharge after delivery, average 5 to 10 days Elevated liver enzymes Thrombocytopenia Hemolysis
Stillbirth From the moment of admission up until discharge after delivery, average 5 to 10 days Intrauterine fetal demise
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
Saint Thomas H
🇵🇦Panama, Panama
Saint Thomas H🇵🇦Panama, Panama